0000908834-23-000047.txt : 20230526
0000908834-23-000047.hdr.sgml : 20230526
20230526131330
ACCESSION NUMBER: 0000908834-23-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200211
FILED AS OF DATE: 20230526
DATE AS OF CHANGE: 20230526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schuler Education Foundation
CENTRAL INDEX KEY: 0001512977
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36385
FILM NUMBER: 23966495
BUSINESS ADDRESS:
STREET 1: 100 N. FIELD DRIVE
STREET 2: SUITE 360
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: 847.607.2066
MAIL ADDRESS:
STREET 1: 100 N. FIELD DRIVE
STREET 2: SUITE 360
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
FORMER NAME:
FORMER CONFORMED NAME: Schuler Family Foundation
DATE OF NAME CHANGE: 20110214
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLASE, INC
CENTRAL INDEX KEY: 0000811240
STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843]
IRS NUMBER: 870442441
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27042 TOWNE CENTRE DRIVE
STREET 2: SUITE 270
CITY: FOOTHILL RANCH
STATE: CA
ZIP: 92610
BUSINESS PHONE: 949-361-1200
MAIL ADDRESS:
STREET 1: 27042 TOWNE CENTRE DRIVE
STREET 2: SUITE 270
CITY: FOOTHILL RANCH
STATE: CA
ZIP: 92610
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC
DATE OF NAME CHANGE: 19941117
FORMER COMPANY:
FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC
DATE OF NAME CHANGE: 19941117
FORMER COMPANY:
FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP
DATE OF NAME CHANGE: 19920708
4
1
form4.xml
X0407
4
2020-02-11
true
0000811240
BIOLASE, INC
BIOL
0001512977
Schuler Education Foundation
100 N. FIELD DRIVE
SUITE 360
LAKE FOREST
IL
60045
true
false
Common Stock
2020-02-11
4
P
0
1307931
0.61
A
10936444
D
Common Stock
2020-06-08
4
S
0
1847649
0.55
D
9088795
D
Common Stock
2020-06-09
4
S
0
2137559
0.54
D
6951236
D
Common Stock
2020-06-10
4
S
0
1733836
0.55
D
5217400
D
Common Stock
2020-07-28
4
C
0
3745000
0.4
A
8962400
D
Common Stock
2020-11-24
4
S
0
71100
0.3
D
8891300
D
Common Stock
2020-11-25
4
S
0
203057
0.29
D
8688243
D
Common Stock
2020-11-30
4
S
0
1115000
0.3
D
7573243
D
Common Stock
2020-12-04
4
S
0
1200000
0.3
D
6373243
D
Common Stock
2020-12-16
4
S
0
90575
0.28
D
6282668
D
Common Stock
2020-12-17
4
S
0
572671
0.28
D
5709997
D
Common Stock
2020-12-18
4
S
0
187774
0.28
D
5522223
D
Series F Convertible Preferred Stock
0.4
2020-07-22
4
A
0
1498
A
2020-07-22
Common Stock
3745000
1498
D
Warrants
0.4
2020-07-22
4
A
0
3745000
A
2020-07-22
2025-07-22
Common Stock
3745000
3745000
D
Series F Convertible Preferred Stock
0.4
2020-07-28
4
C
0
1498
D
2020-07-22
Common Stock
3745000
0
D
This late filing is due to inadvertent administrative error.
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5399 and $0.5643, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5430 and $0.5601, inclusive.
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5485 and $0.5656, inclusive.
In connection with a public offering by the Issuer, on July 22, 2020, the Reporting Person acquired (i) 1,498 shares of Series F Convertible Preferred Stock, each of which is convertible into 2,500 shares of Common Stock, for a total of up to 3,745,000 shares of Common Stock, and (ii) 3,745,000 Warrants, each of which is exercisable to purchase one share of Common Stock, for a total of up to 3,745,000 shares of Common Stock, for an aggregate purchase price of $1,500,000.
Each share of Series F Convertible Preferred Stock is convertible at the Issuer's option at any time on or after July 22, 2021 or at the option of the Reporting Person at any time.
On July 28, 2020, the Reporting Person converted 1,498 shares of Series F Convertible Preferred Stock into 3,745,000 shares of Common Stock.
/s/ Jack W. Schuler, President
2023-05-26